Answers are grounded in this paper and cite their sources.
Fracture rate is increased in patients with active acromegaly and those in remission. Abnormalities of bone microstructure are present in patients with active disease and persist despite biochemical control after surgery. Effects of treatment with the GH receptor antagonist pegvisomant on bone microstructure were unknown.
No takes yet. Share an insight, caveat, or question.
Kuker et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: